Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model
Matteo Colombo(Ospedale Civile Di Ivrea), Raffaella Chiaramonte(University of Milan), Alfonso Neri, S. Garavelli(University of Milan), Anna Pistocchi(University of Milan), Domenica Giannandrea(University of Milan), R. Colella(University of Milan), Mara Mazzola(University of Milan), Elisa Lazzari(University of Trieste), Maria Teresa Palano(University of Milan), M. Alejandro Barbieri(Florida International University), Natalia Platonova(University of Milan)
Unknown
October 24, 2018
Cited by 0
Related Papers
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
|Nature Communications|2017|142
Inflammatory bowel disease in children and adolescents in Italy: Data from the pediatric national IBD register (1996–2003)
|Inflammatory Bowel Diseases|2008|124
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells
|Biochemical Pharmacology|2007|118
Senescence-Dependent Regulation of Type 1 Plasminogen Activator Inhibitor in Human Vascular Endothelial Cells
|Experimental Cell Research|1995|110